COSMO PHARMACEUTICALS N.V.

Analyst Reco. Cosmo Pharmaceuticals N.V.

Equities

COPN

NL0011832936

Market Closed - Swiss Exchange Other stock markets 11:30:02 2024-05-17 am EDT			5-day change	1st Jan Change
72.9 ^CHF	-0.82%		+1.67%	+43.22%

Apr. 26	Cosmo Pharmaceuticals N.V. Announces Executive Changes at the Upcoming Annual General Meeting on 24 May 2024	CI
Apr. 25	Cosmo Pharmaceuticals Names New CEO, Chairman	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Berenberg Lifts Price Target on Cosmo Pharmaceuticals, Maintains Buy Recommendation	Jan. 03	MT
Berenberg EU Opportunities Conference	23-03-12	FA
Cosmo Pharmaceuticals Partner Medtronic Says GI Genius Endoscopy Lowers Colorectal Polyps Miss Rate	22-03-18	MT
Cosmo Pharmaceuticals' GI Genius Device Cuts Adenoma, Polyp Miss Rate in Colonoscopy	21-11-19	MT
Cosmo Pharmaceuticals N.V. Detects Study Shows AI Assistance Using GI Genius? Reduces Missed Polyp Rate by Nearly 50% on Initial Colonoscopy	21-11-19	CI
COSMO PHARMACEUTICALS N : Research Partners Lowers Price Target on Cosmo Pharmaceuticals, Maintains Buy Recommendation	21-03-29	MT
COSMO PHARMACEUTICALS N : Research Partners Lifts Price Target on Cosmo Pharmaceutical, Maintains Buy Recommendation	21-01-12	MT
Berenberg European Conference	18-12-04	FA
Berenberg USA Conference	18-05-21	FA
Berenberg European Conference	17-05-23	FA

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.

BENEFIT NOW